SCHEMBL20328751

SCHEMBL20328751

CC(C)(C)CCNCCN1CCCCC1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.48
PRMT6 Q96LA8 1/20 0.48
PRMT8 Q9NR22 1/20 0.48
SIGMAR1 Q99720 3/20 0.43
ACE2 Q9BYF1 1/20 0.42
DPP7 Q9UHL4 1/20 0.41
CA12 O43570 3/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA9 Q16790 3/20 0.39
HRH3 Q9Y5N1 1/20 0.38
KDM1A O60341 1/20 0.38
NPC1 O15118 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20328749 0.98 CARM1 (0.50) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL20328754 0.84 ACE2 (0.47) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL21120600 0.83 CARM1 (0.44) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL31326654 0.82 CARM1 (0.59) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL4288469 0.82 CARM1 (0.59) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL20328752 0.82 SIGMAR1 (0.51) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL21594700 0.82 CARM1 (0.50) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL2994842 0.81 SMN1; SMN2 (0.44) ACE2CA12CA1CA2CA9
SCHEMBL20333683 0.81 CARM1 (0.45) CARM1PRMT6PRMT8SIGMAR1ACE2
SCHEMBL10410535 0.80 CARM1 (0.62) CARM1PRMT6PRMT8SIGMAR1ACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230399303-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same UNIV YALE (US) 2023-12-14 US disclosed
US-20230399303-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same UNIV YALE (US) 2023-12-14 US disclosed
US-10968198-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor YALE UNIVERSITY (US) 2021-04-06 US disclosed
US-20190276425-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2019-09-12 US disclosed
US-10336721-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor YALE UNIVERSITY (US) 2019-07-02 US disclosed
US-20180179176-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2018-06-28 US disclosed
US-20180179176-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR UNIV YALE (US) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968198-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor MIF, MMP12, CSF1R CARM1 2581/4885PRMT6 1317/4885PRMT8 1985/4885
US-10336721-B2 Biaryltriazole inhibitors of macrophage migration inhibitory factor MIF, MMP12, CSF1R CARM1 2581/4885PRMT6 1317/4885PRMT8 1985/4885
US-20180179176-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR MIF, MMP12, CSF1R CARM1 2581/4885PRMT6 1317/4885PRMT8 1985/4885
US-20190276425-A1 BIARYLTRIAZOLE INHIBITORS OF MACROPHAGE MIGRATION INHIBITORY FACTOR MIF, MMP12, CSF1R CARM1 2581/4885PRMT6 1317/4885PRMT8 1985/4885
US-20230399303-A1 Macrophage Migration Inhibitory Factor Inhibitors, and Methods of Making and Using Same MIF, MMP12, METAP1 CARM1 1063/4885PRMT6 217/4885PRMT8 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.